annual FCF:
-$144.68M+$127.67M(+46.88%)Summary
- As of today (September 15, 2025), CRSP annual free cash flow is -$144.68 million, with the most recent change of +$127.67 million (+46.88%) on December 31, 2024.
- During the last 3 years, CRSP annual FCF has fallen by -$601.94 million (-131.64%).
- CRSP annual FCF is now -131.64% below its all-time high of $457.27 million, reached on December 31, 2021.
Performance
CRSP Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$114.00M-$59.84M(-110.51%)Summary
- As of today (September 15, 2025), CRSP quarterly free cash flow is -$114.00 million, with the most recent change of -$59.84 million (-110.51%) on June 30, 2025.
- Over the past year, CRSP quarterly FCF has dropped by -$17.71 million (-18.39%).
- CRSP quarterly FCF is now -114.64% below its all-time high of $778.55 million, reached on June 30, 2021.
Performance
CRSP quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$325.57M-$17.71M(-5.75%)Summary
- As of today (September 15, 2025), CRSP TTM free cash flow is -$325.57 million, with the most recent change of -$17.71 million (-5.75%) on June 30, 2025.
- Over the past year, CRSP TTM FCF has dropped by -$199.52 million (-158.30%).
- CRSP TTM FCF is now -164.83% below its all-time high of $502.19 million, reached on June 30, 2021.
Performance
CRSP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
CRSP Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.9% | -18.4% | -158.3% |
| 3 y3 years | -131.6% | +24.8% | +36.9% |
| 5 y5 years | -389.4% | -246.7% | -818.2% |
CRSP Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -131.6% | +72.8% | -204.6% | +24.8% | -158.3% | +38.9% |
| 5 y | 5-year | -131.6% | +72.8% | -114.6% | +24.8% | -164.8% | +38.9% |
| alltime | all time | -131.6% | +72.8% | -114.6% | +24.8% | -164.8% | +38.9% |
CRSP Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$114.00M(+110.5%) | -$325.57M(+5.8%) |
| Mar 2025 | - | -$54.15M(+7.7%) | -$307.86M(+112.8%) |
| Dec 2024 | -$144.68M(-46.9%) | -$50.28M(-53.1%) | -$144.68M(-24.3%) |
| Sep 2024 | - | -$107.13M(+11.3%) | -$191.20M(+51.7%) |
| Jun 2024 | - | -$96.29M(-188.3%) | -$126.04M(-24.3%) |
| Mar 2024 | - | $109.03M(-212.6%) | -$166.55M(-38.3%) |
| Dec 2023 | -$272.35M(-48.9%) | -$96.81M(+130.6%) | -$269.85M(-7.8%) |
| Sep 2023 | - | -$41.97M(-69.3%) | -$292.55M(-19.1%) |
| Jun 2023 | - | -$136.80M(-2483.3%) | -$361.81M(-3.9%) |
| Mar 2023 | - | $5.74M(-104.8%) | -$376.60M(-29.3%) |
| Dec 2022 | -$532.93M(-216.5%) | -$119.52M(+7.4%) | -$532.93M(+4.8%) |
| Sep 2022 | - | -$111.23M(-26.6%) | -$508.63M(-1.4%) |
| Jun 2022 | - | -$151.59M(+0.7%) | -$515.77M(-224.5%) |
| Mar 2022 | - | -$150.59M(+58.1%) | $414.37M(-9.4%) |
| Dec 2021 | $457.27M(-278.1%) | -$95.22M(-19.6%) | $457.27M(-1.7%) |
| Sep 2021 | - | -$118.38M(-115.2%) | $465.04M(-7.4%) |
| Jun 2021 | - | $778.55M(-823.0%) | $502.19M(-262.4%) |
| Mar 2021 | - | -$107.69M(+23.1%) | -$309.25M(+20.5%) |
| Dec 2020 | -$256.72M | -$87.45M(+7.7%) | -$256.72M(+53.9%) |
| Sep 2020 | - | -$81.22M(+147.0%) | -$166.85M(-468.1%) |
| Jun 2020 | - | -$32.88M(-40.4%) | $45.33M(+14.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$55.17M(-2375.8%) | $39.66M(-20.7%) |
| Dec 2019 | $49.99M(-150.5%) | $2.42M(-98.1%) | $49.99M(+174.7%) |
| Sep 2019 | - | $130.96M(-439.7%) | $18.20M(-113.6%) |
| Jun 2019 | - | -$38.56M(-14.0%) | -$133.42M(+10.6%) |
| Mar 2019 | - | -$44.83M(+52.6%) | -$120.60M(+21.8%) |
| Dec 2018 | -$99.01M(+27.1%) | -$29.37M(+42.2%) | -$99.01M(+16.9%) |
| Sep 2018 | - | -$20.66M(-19.7%) | -$84.69M(+2.2%) |
| Jun 2018 | - | -$25.74M(+10.7%) | -$82.89M(+11.3%) |
| Mar 2018 | - | -$23.24M(+54.5%) | -$74.45M(-4.4%) |
| Dec 2017 | -$77.91M(+39.4%) | -$15.05M(-20.2%) | -$77.91M(-8.3%) |
| Sep 2017 | - | -$18.86M(+9.0%) | -$84.96M(+9.7%) |
| Jun 2017 | - | -$17.30M(-35.2%) | -$77.43M(+3.5%) |
| Mar 2017 | - | -$26.70M(+20.8%) | -$74.78M(+28.2%) |
| Dec 2016 | -$55.88M(-195.9%) | -$22.10M(+95.0%) | -$58.33M(+61.0%) |
| Sep 2016 | - | -$11.33M(-22.7%) | -$36.23M(+45.5%) |
| Jun 2016 | - | -$14.65M(+43.0%) | -$24.90M(+91.1%) |
| Mar 2016 | - | -$10.25M(+268.3%) | -$13.03M(+198.5%) |
| Dec 2015 | $58.27M(-1315.8%) | - | - |
| Jun 2015 | - | -$2.78M(+75.7%) | -$4.37M(+175.7%) |
| Mar 2015 | - | -$1.58M | -$1.58M |
| Dec 2014 | -$4.79M | - | - |
FAQ
- What is CRISPR Therapeutics AG annual free cash flow?
- What is the all time high annual FCF for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual FCF year-on-year change?
- What is CRISPR Therapeutics AG quarterly free cash flow?
- What is the all time high quarterly FCF for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly FCF year-on-year change?
- What is CRISPR Therapeutics AG TTM free cash flow?
- What is the all time high TTM FCF for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM FCF year-on-year change?
What is CRISPR Therapeutics AG annual free cash flow?
The current annual FCF of CRSP is -$144.68M
What is the all time high annual FCF for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual free cash flow is $457.27M
What is CRISPR Therapeutics AG annual FCF year-on-year change?
Over the past year, CRSP annual free cash flow has changed by +$127.67M (+46.88%)
What is CRISPR Therapeutics AG quarterly free cash flow?
The current quarterly FCF of CRSP is -$114.00M
What is the all time high quarterly FCF for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly free cash flow is $778.55M
What is CRISPR Therapeutics AG quarterly FCF year-on-year change?
Over the past year, CRSP quarterly free cash flow has changed by -$17.71M (-18.39%)
What is CRISPR Therapeutics AG TTM free cash flow?
The current TTM FCF of CRSP is -$325.57M
What is the all time high TTM FCF for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM free cash flow is $502.19M
What is CRISPR Therapeutics AG TTM FCF year-on-year change?
Over the past year, CRSP TTM free cash flow has changed by -$199.52M (-158.30%)